ChatGPT (GPT-4) passed the Japanese National License Examination for Pharmacists in 2022, answering all items including those with diagrams: a descriptive study.
Sato Hiroyasu, Ogasawara Katsuhiko·Journal of educational evaluation for health professions
PURPOSE: The objective of this study was to assess the performance of ChatGPT (GPT-4) on all items, including those with diagrams, in the Japanese National License Examination for Pharmacists (JNLEP) and compare it with the previous GPT-3.5 model’s performance. METHODS: The 107th JNLEP, conducted in 2022, with…